Top Markets
Coin of the day
Arctic Bioscience AS Arctic Bioscience AS

Arctic Bioscience AS

ABS
Rang in aandelen #33058
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Aandeelprijs
$0.3144463
Marktkapitalisatie
$8.48M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-2.55%
Land
NO
Handel Arctic Bioscience AS (ABS)

Categorie

Dividendrendementgeschiedenis voor Arctic Bioscience AS (ABS)
Het dividendrendement (TTM) van Arctic Bioscience AS (aandelsymbool: ABS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Arctic Bioscience AS (ABS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten